In findings likely to make it easier and faster for stem cell biologists to generate patient-specific embryonic-like stem cells, researchers at Children's Hospital Boston have reprogrammed adult blood cells into induced pluripotent stem (iPS) cells.

Intercell's investigational vaccine enhancement patch system for avian H5N1 influenza has failed a Phase II study. The company is working under a contract with Human and Health services (HHS) to develop a dose-sparing approach with potential for a single dose immunization combining a H5N1 vaccine with Intercell's LT adjuvant patch.

[adsense:336x280:8701650588]

Roche Diagnostics has announced the Asia Pacific launch of the GS Junior System, the company’s new next-generation DNA sequencing platform for life science research. The GS Junior System, developed by 454 Life Sciences, a Roche company, provides an integrated sequencing and bioinformatics solution, all in a size that is no bigger than a typical desktop laser printer.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

INC research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity.

Part of the USD 265 million Aarti Group of Industries, Aarti Drugs Ltd (ADL) was established way back in in 1984.

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area.

Mercury Laboratories   has  47 years  record performance which is unsurpassed this record has been accomplished through the company's participation in the  WHO/GMP system implementation,  ISO 9002 certified specification and worker/staff training through quality circle programmed. This has resulted in timely delivery with world-class quality at competitive price.

[adsense:336x280:8701650588]

Crimson Interactive Pvt. Ltd. is an organization of member brands providing English language solutions to individuals and corporate customers in the Far East. Crimson's member firms deliver services in three professional areas: Academic Editing, English Transcription, and Translation. We have served more than 6000 clients and are proud to be amongst the top three editing players in Japan.

Marksans Pharma, Headquartered in Mumbai (India) is vertically integrated global player with strong presence across the entire value chain from Active Pharmaceuticals Ingredient's (APIs) to formulations to biopharmaceuticals. We are also actively engaged in R&D and offers Contract Research and Manufacturing Services (CRAMS) to global pharmaceutical companies.

[adsense:336x280:8701650588]

Ideal Cures, a young company in the field of Pharmaceutical Film Coatings has established itself as a reliable source for all your Film Coating needs for Tablet Coating, Pellet Coating, Soft Gelatin Capsule Coating, Enteric Coating, Moisture Protective Coating, Gloss Coating, Aqueous Film Coating, Taste Masking, Odour Masking etc. for ethical as well as for Herbal Drugs.

[adsense:336x280:8701650588]

ONLINE COMPETITION FAIR 2010

The 62nd Indian Pharmaceutical Congress (IPC), hosted by Indian Hospital Pharmacists’ Association (IHPA), will be held from December 17 to 19, 2010 in Manipal University.

Applications are invited from eligible candidates for admission to the following postgraduate programmes of the Institute for the session 2010-11:

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

CIMAP(CENTRAL INSTITUTE OF MEDICINAL & AROMATIC PLANTS) is committed to provide global standards for plant based research, processes and products using green technology mode while generating an ambience of team spirit, development of research and technology, expertise and human resource and modernization of infrastructure to ensure sustained clientele from agriculture, society and industry.